These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 37111579)

  • 41. Nanomaterial-based ophthalmic drug delivery.
    Xie G; Lin S; Wu F; Liu J
    Adv Drug Deliv Rev; 2023 Sep; 200():115004. PubMed ID: 37433372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Light-responsive in situ forming injectable implants for effective drug delivery to the posterior segment of the eye.
    Bisht R; Jaiswal JK; Chen YS; Jin J; Rupenthal ID
    Expert Opin Drug Deliv; 2016 Jul; 13(7):953-62. PubMed ID: 26967153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydrogel-based ocular drug delivery systems for hydrophobic drugs.
    Torres-Luna C; Fan X; Domszy R; Hu N; Wang NS; Yang A
    Eur J Pharm Sci; 2020 Nov; 154():105503. PubMed ID: 32745587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances and limitations of drug delivery systems formulated as eye drops.
    Jumelle C; Gholizadeh S; Annabi N; Dana R
    J Control Release; 2020 May; 321():1-22. PubMed ID: 32027938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System.
    Akhter MH; Ahmad I; Alshahrani MY; Al-Harbi AI; Khalilullah H; Afzal O; Altamimi ASA; Najib Ullah SNM; Ojha A; Karim S
    Gels; 2022 Jan; 8(2):. PubMed ID: 35200463
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ocular drug delivery.
    Gaudana R; Ananthula HK; Parenky A; Mitra AK
    AAPS J; 2010 Sep; 12(3):348-60. PubMed ID: 20437123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches.
    Agrahari V; Agrahari V; Mandal A; Pal D; Mitra AK
    Expert Opin Drug Deliv; 2017 Oct; 14(10):1145-1162. PubMed ID: 27967247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesenchymal Stem Cell-Derived Exosomes in Ophthalmology: A Comprehensive Review.
    Wu KY; Ahmad H; Lin G; Carbonneau M; Tran SD
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111652
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A review on recent drug delivery systems for posterior segment of eye.
    Nayak K; Misra M
    Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biodegradable implants for sustained drug release in the eye.
    Lee SS; Hughes P; Ross AD; Robinson MR
    Pharm Res; 2010 Oct; 27(10):2043-53. PubMed ID: 20535532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Minimally invasive microneedles for ocular drug delivery.
    Thakur Singh RR; Tekko I; McAvoy K; McMillan H; Jones D; Donnelly RF
    Expert Opin Drug Deliv; 2017 Apr; 14(4):525-537. PubMed ID: 27485251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promising therapeutic drug delivery systems for glaucoma: a comprehensive review.
    Singh RB; Ichhpujani P; Thakur S; Jindal S
    Ther Adv Ophthalmol; 2020; 12():2515841420905740. PubMed ID: 32206746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trojan Microparticles Potential for Ophthalmic Drug Delivery.
    Esteban-Pérez S; Bravo-Osuna I; Andrés-Guerrero V; Molina-Martínez IT; Herrero-Vanrell R
    Curr Med Chem; 2020; 27(4):570-582. PubMed ID: 31486746
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Use of Polymer Blends in the Treatment of Ocular Diseases.
    Arribada RG; Behar-Cohen F; de Barros ALB; Silva-Cunha A
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.
    Durak S; Esmaeili Rad M; Alp Yetisgin A; Eda Sutova H; Kutlu O; Cetinel S; Zarrabi A
    Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32570885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives.
    Han H; Li S; Xu M; Zhong Y; Fan W; Xu J; Zhou T; Ji J; Ye J; Yao K
    Adv Drug Deliv Rev; 2023 May; 196():114770. PubMed ID: 36894134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanotechnology-based strategies for treatment of ocular disease.
    Weng Y; Liu J; Jin S; Guo W; Liang X; Hu Z
    Acta Pharm Sin B; 2017 May; 7(3):281-291. PubMed ID: 28540165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymeric, injectable, intravitreal hydrogel devices for posterior segment applications and interventions.
    Anwary M; Kumar P; du Toit LC; Choonara YE; Pillay V
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1074-1081. PubMed ID: 29916734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery.
    Cholkar K; Patel A; Vadlapudi AD; Mitra AK
    Recent Pat Nanomed; 2012; 2(2):82-95. PubMed ID: 25400717
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colloidal nanosystems with mucoadhesive properties designed for ocular topical delivery.
    Silva B; São Braz B; Delgado E; Gonçalves L
    Int J Pharm; 2021 Sep; 606():120873. PubMed ID: 34246741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.